SCHEMBL256558

SCHEMBL256558

CCn1cc(CNC[C@@H](O)CCc2ccccc2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
MAPT P10636 1/20 0.47
ACHE P22303 1/20 0.47
ALDH1A1 P00352 5/20 0.42
GAA P10253 1/20 0.42
KDM4E B2RXH2 1/20 0.42
BACE1 P56817 4/20 0.41
CTSD P07339 3/20 0.41
BACE2 Q9Y5Z0 3/20 0.41
DNM1 Q05193 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
PDCD1 Q15116 1/20 0.38
CD274 Q9NZQ7 1/20 0.38
TSHR P16473 1/20 0.38
HPGD P15428 1/20 0.37
S1PR2 O95136 1/20 0.37
S1PR4 O95977 1/20 0.37
S1PR1 P21453 1/20 0.37
S1PR3 Q99500 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175480 0.79 LMNA (0.48) LMNAMAPTACHEALDH1A1KDM4E
SCHEMBL6694692 0.78 DNM1 (0.54) LMNAMAPTALDH1A1GAADNM1
SCHEMBL5219603 0.78 DNM1 (0.54) LMNAMAPTALDH1A1GAADNM1
Hydrochloric Acid SCHEMBL5219543 0.78 LMNA (0.47) LMNAMAPTACHEALDH1A1KDM4E
SCHEMBL5930378 0.74 CYP1A2 (0.56) LMNAACHEALDH1A1HPGD
SCHEMBL5930107 0.73 SMN1; SMN2 (0.48) LMNAMAPTALDH1A1GAADNM1
SCHEMBL5223199 0.71 LMNA (0.46) LMNAMAPTACHEALDH1A1GAA
SCHEMBL5223191 0.71 LMNA (0.46) LMNAMAPTACHEALDH1A1GAA
SCHEMBL5391448 0.71 ABCB1 (0.53) LMNAALDH1A1MEN1KMT2ATSHR
SCHEMBL15101698 0.71 DNM1 (0.53) LMNAALDH1A1KDM4EBACE1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed